Skip to main content

Current Clinical Trials

Currently, we are conducting the following Clinical Trials:

ONSTRIDE-2

ONSTRIDE-2 is a clinical research study for adults with idiopathic hypersomnia (IH). This study will test an investigational daily oral drug (HBS-301) to learn about its safety and effectiveness in participants with IH who experience excessive daytime sleepiness and other IH symptoms.

Participation in the ONSTRIDE-2 study is expected to last approximately 16 weeks. After the final study visit, you may have the opportunity to participate in an open-label extension period where all participants will receive HBS-301 for approximately 1 year.

Who can join the ONSTRIDE-2 study?

You may be able to join this study if you are:

  • 18 years of age or older
  • Diagnosed with idiopathic hypersomnia
  • If on a stable dose of a current medication, including
  • sodium oxybate, must continue it through study completion
  • Not pregnant or planning pregnancy
  • Not taking a prohibited medication
  • Able to give informed consent

How do I participate?

Call, email, or stop by. We will answer whatever you want to ask, and you are under no obligation to join anything.

ONSTRIDE-1

ONSTRIDE-1 is a clinical research study for adults with narcolepsy type 1 (NT1) or type 2 (NT2). This study will test an investigational daily oral drug (HBS-301) to learn about its safety and effectiveness in participants with NT1 or NT2.

Participation in the ONSTRIDE-1 study is expected to last approximately 16 weeks. After completing the 8-week Study Treatment Period, you may have the opportunity to participate in an open-label extension period where all participants will receive HBS-301 for approximately 1 year.

Who can join the ONSTRIDE-2 study?

You may be able to join this study if you are:

  • 18 years of age or older
  • Diagnosed with narcolepsy (type 1 or 2)
  • If on a stable dose of a current medication,
  • must continue it through study completion
  • Not pregnant or planning pregnancy
  • Not on a prohibited medication
  • Able to give informed consent

How do I participate?

Call, email, or stop by. We will answer whatever you want to ask, and you are under no obligation to join anything.